CellKey
The AI engine Fit Assessment
BetaThe company effectively leverages machine learning for glycopeptide analysis, enabling pattern discovery and expanding therapeutics while focusing on biomarker identification.
Blurb
CellKey is an AI-based glycopeptide analysis solution that provides protein and glycoprotein analysis and biomarker research services.
HQ Location
Cheongju-si (South Korea)
Founded
2019
Employees
11 - 50
Total funding raised
Not available
Funding Status
Seed, February 28, 2022
Subspaces
- Biomarker Identification
CellKey develops an LC/MS-derived analytic pipeline (SpAC9) that enables proprietary AI/ML-based glycoprotein analysis with enhanced accuracy and reduced time & cost.